Depleted mucosal antioxidant defences in inflammatory bowel disease

Free Radical Biology & Medicine
G D Buffinton, W F Doe

Abstract

Experimental approaches designed to define the role of reactive oxygen and nitrogen species generated by inflammatory cells in the tissue injury seen in inflammatory bowel disease rarely consider the chemical antioxidant defences against such increased oxidant stress in the mucosa. In this investigation, we have analysed components of the aqueous and lipid phase antioxidant mucosal defences by measuring the total peroxyl radical scavenging capacity and the levels of urate, glutathione, alpha-tocopherol, and ubiquinol-10 in paired noninflamed and inflamed mucosal biopsies from inflammatory bowel disease patients. Compared to paired noninflamed mucosa, decreases were observed in inflamed mucosa for total peroxyl radical scavenging capacity (55%, p = 0.0031), urate [Crohn's disease (CD), 62.2%, p = 0.066; ulcerative colitis (UC), 47.3%, p = 0.031], glutathione (UC, 59%, 7/8 patients, ns), total glutathione (UC 65.2%, 6/8 patients, ns), ubiquinol-10 (CD, 75.7%, p = 0.03; UC, 90.5%, p = 0.005). The mean alpha-tocopherol content was unchanged. These observations support our earlier findings of decreased reduced and total ascorbic acid in inflamed IBD mucosa and demonstrate that the loss of chemical antioxidant defences affects almost...Continue Reading

References

Jan 15, 1979·Analytical Biochemistry·C F BrunkT W James
Jan 1, 1992·Free Radical Biology & Medicine·C F Babbs
Jan 1, 1992·Annals of the New York Academy of Sciences·M B Grisham, T Yamada
Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·R StockerB Frei
Jan 1, 1991·Free Radical Research Communications·J EmeritA Thuillier
Dec 1, 1990·Inflammation·M B GrishamE A Deitch
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J MårtenssonA Meister
Jan 1, 1989·Free Radical Biology & Medicine·S MatalonB A Freeman
Jul 1, 1989·JPEN. Journal of Parenteral and Enteral Nutrition·C DolzM A Gassull
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B FreiB N Ames
Jan 1, 1985·Advances in Enzyme Regulation·E Cadenas, H Sies
Mar 1, 1985·Scandinavian Journal of Gastroenterology·C O'MorainT J Peters
Feb 1, 1995·Free Radical Research·G D Buffinton, W F Doe
Feb 20, 1993·Lancet·S J MiddletonJ O Hunter
Jul 1, 1993·Comparative Biochemistry and Physiology. Comparative Physiology·F J Kelly, K H Cheeseman
Jan 20, 1994·Biochemical Pharmacology·T D Nguyen, A T Canada
Jun 1, 1993·Free Radical Biology & Medicine·B F Becker
May 25, 1993·Biochemical Pharmacology·O Benard, K A Balasubramanian

❮ Previous
Next ❯

Citations

Oct 1, 1997·Inflammatory Bowel Diseases·A C BlackburnG D Buffinton
Jan 6, 1999·Archives of Pharmacal Research·M W SonB K Kim
Mar 15, 2011·Pediatric Surgery International·Naira BaregamianDai H Chung
Apr 15, 2006·Digestive Diseases and Sciences·Ali CetinkayaYakup Gumusalan
Dec 8, 2006·Digestive Diseases and Sciences·M A PélissierP Pochart
Dec 21, 2002·Clinical Biochemistry·Ahmet TüzünKemal Dağalp
Feb 7, 2001·Mutation Research·A L Jackson, L A Loeb
Nov 14, 2003·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·M A AlzoghaibiM F Graham
Jul 20, 2002·Free Radical Biology & Medicine·Kevin P PavlickMatthew B Grisham
Jul 29, 1998·Free Radical Biology & Medicine·A C BlackburnG D Buffinton
Sep 1, 1999·Free Radical Biology & Medicine·A C BlackburnG D Buffinton
Sep 18, 1997·Nutrition·T R ZieglerD P Griffith
Apr 12, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Douglas L SeidnerStephen J Demichele
Mar 1, 2012·Journal of Agricultural and Food Chemistry·David D KittsHao Jing
Dec 12, 2001·Alimentary Pharmacology & Therapeutics·J CarrierJ P Allard
Nov 28, 2002·Alimentary Pharmacology & Therapeutics·L Kruidenier, H W Verspaget
Mar 10, 2001·Antioxidants & Redox Signaling·N YoshidaM Kondo
Feb 12, 2013·Antioxidants & Redox Signaling·Hye-Won YumYoung-Joon Surh
Jul 14, 2009·Evidence-based Complementary and Alternative Medicine : ECAM·Sílvia Helena CestariLuiz Claudio Di Stasi
Jan 1, 1997·Journal of Clinical Gastroenterology·D Jourd'heuilM B Grisham
Feb 12, 2002·Inflammatory Bowel Diseases·Khaled O ShebaniJames M Becker
Jul 1, 1997·Journal of Gastroenterology and Hepatology·B S RamakrishnaK A Balasubramanian
Apr 11, 2008·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M S El MuhtasebI G Finlay
Feb 15, 2000·Gut·D M McCafferty
Mar 11, 2003·Annual Review of Nutrition·Thomas R ZieglerDean P Jones
Jul 1, 1996·The Journal of Clinical Investigation·S J McKenzieW F Doe
Jul 2, 2008·Biological & Pharmaceutical Bulletin·Ana Carolina LuchiniLuiz Cláudio Di Stasi
Sep 22, 2011·Canadian Journal of Surgery. Journal Canadien De Chirurgie·Gulgun TahanHafize Uzun
May 14, 2008·World Journal of Gastroenterology : WJG·Luis G GuijarroAmado-Salvador Pena
Oct 22, 2008·World Journal of Gastroenterology : WJG·Seyed-Amir MirbagheriMannan Hajimahmoodi
Jun 13, 2012·World Journal of Gastroenterology : WJG·Chourouk EttreikiPauline M Anton
Feb 13, 2014·International Journal of Molecular Sciences·Marilia da S Nascimento SantosEdda Lisboa Leite
May 15, 2013·Toxicology and Applied Pharmacology·Marwa M NagibAmani E Khalifa
Mar 26, 2013·Journal of Crohn's & Colitis·Marco Antonio S PintoCyrla Zaltman
Aug 1, 2008·Nutrition Reviews·Denish MoorthyIrwin H Rosenberg
Apr 4, 2007·Digestive Diseases and Sciences·Ali RezaieMohammad Abdollahi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.